Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Identifying potential inhibitors for wild-type EGFR tyrosine kinase through a cross-talk pathway strategy and an in-silico drug repurposing method.

Abdelmalek D et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 305185
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.